392 related articles for article (PubMed ID: 21497451)
1. Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.
Sperduto PW; Kased N; Roberge D; Xu Z; Shanley R; Luo X; Sneed PK; Chao ST; Weil RJ; Suh J; Bhatt A; Jensen AW; Brown PD; Shih HA; Kirkpatrick J; Gaspar LE; Fiveash JB; Chiang V; Knisely JP; Sperduto CM; Lin N; Mehta M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2111-7. PubMed ID: 21497451
[TBL] [Abstract][Full Text] [Related]
2. Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases.
Subbiah IM; Lei X; Weinberg JS; Sulman EP; Chavez-MacGregor M; Tripathy D; Gupta R; Varma A; Chouhan J; Guevarra RP; Valero V; Gilbert MR; Gonzalez-Angulo AM
J Clin Oncol; 2015 Jul; 33(20):2239-45. PubMed ID: 25987700
[TBL] [Abstract][Full Text] [Related]
3. The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer.
Sperduto PW; Kased N; Roberge D; Chao ST; Shanley R; Luo X; Sneed PK; Suh J; Weil RJ; Jensen AW; Brown PD; Shih HA; Kirkpatrick J; Gaspar LE; Fiveash JB; Chiang V; Knisely JP; Sperduto CM; Lin N; Mehta M
J Neurooncol; 2013 May; 112(3):467-72. PubMed ID: 23462853
[TBL] [Abstract][Full Text] [Related]
4. External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.
Griguolo G; Jacot W; Kantelhardt E; Dieci MV; Bourgier C; Thomssen C; Bailleux C; Miglietta F; Braccini AL; Conte P; Ferrero JM; Guarneri V; Darlix A
Breast; 2018 Feb; 37():36-41. PubMed ID: 29073498
[TBL] [Abstract][Full Text] [Related]
5. Prolonged survival after diagnosis of brain metastasis from breast cancer: contributing factors and treatment implications.
Honda Y; Aruga T; Yamashita T; Miyamoto H; Horiguchi K; Kitagawa D; Idera N; Goto R; Kuroi K
Jpn J Clin Oncol; 2015 Aug; 45(8):713-8. PubMed ID: 25981620
[TBL] [Abstract][Full Text] [Related]
6. Analysis of survival outcomes based on molecular subtypes in breast cancer brain metastases: A single institutional cohort.
Jeon W; Jang BS; Jeon SH; Kim JH; Kim YJ; Kim SH; Kim CY; Han JH; Kim IA
Breast J; 2018 Nov; 24(6):920-926. PubMed ID: 30596408
[TBL] [Abstract][Full Text] [Related]
7. Breast Cancer Survival Analysis Based on Immunohistochemistry Subtypes (ER/PR/HER2): a Retrospective Cohort Study.
Poorolajal J; Nafissi N; Akbari ME; Mahjub H; Esmailnasab N; Babaee E
Arch Iran Med; 2016 Oct; 19(10):680-686. PubMed ID: 27743431
[TBL] [Abstract][Full Text] [Related]
8. New breast cancer recursive partitioning analysis prognostic index in patients with newly diagnosed brain metastases.
Niwińska A; Murawska M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2065-71. PubMed ID: 21596487
[TBL] [Abstract][Full Text] [Related]
9. Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today.
Sperduto PW; Mesko S; Li J; Cagney D; Aizer A; Lin NU; Nesbit E; Kruser TJ; Chan J; Braunstein S; Lee J; Kirkpatrick JP; Breen W; Brown PD; Shi D; Shih HA; Soliman H; Sahgal A; Shanley R; Sperduto W; Lou E; Everett A; Boggs DH; Masucci L; Roberge D; Remick J; Plichta K; Buatti JM; Jain S; Gaspar LE; Wu CC; Wang TJC; Bryant J; Chuong M; Yu J; Chiang V; Nakano T; Aoyama H; Mehta MP
Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):334-343. PubMed ID: 32084525
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Brain Metastasis-Free Interval in Patients with Breast Cancer Brain Metastases.
Hulsbergen AFC; Lamba N; Claes A; Kavouridis VK; Lin NU; Smith TR; Verhoeff JJC; Broekman MLD
World Neurosurg; 2019 Aug; 128():e157-e164. PubMed ID: 31035019
[TBL] [Abstract][Full Text] [Related]
12. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer subtype as a predictor for outcomes and control in the setting of brain metastases treated with stereotactic radiosurgery.
Grubb CS; Jani A; Wu CC; Saad S; Qureshi YH; Nanda T; Yaeh A; Rozenblat T; Sisti MB; Bruce JN; McKhann GM; Sheth SA; Lesser J; Cheng SK; Isaacson SR; Lassman AB; Connolly EP; Wang TJ
J Neurooncol; 2016 Mar; 127(1):103-10. PubMed ID: 26615564
[TBL] [Abstract][Full Text] [Related]
14. Brain metastases in breast cancer: clinical and pathologic characteristics associated with improvements in survival.
Melisko ME; Moore DH; Sneed PK; De Franco J; Rugo HS
J Neurooncol; 2008 Jul; 88(3):359-65. PubMed ID: 18398574
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Factors and Survival Outcomes among Patients with Breast Cancer and Brain Metastases at Diagnosis: A National Cancer Database Analysis.
Zimmerman BS; Seidman D; Cascetta KP; Ru M; Moshier E; Tiersten A
Oncology; 2021; 99(5):280-291. PubMed ID: 33652435
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis.
Leone JP; Leone J; Zwenger AO; Iturbe J; Leone BA; Vallejo CT
Eur J Cancer; 2017 Mar; 74():17-25. PubMed ID: 28335884
[TBL] [Abstract][Full Text] [Related]
19. Validity of the graded prognostic assessment-derived index to predict brain-metastatic patients' survival after Gamma Knife radiosurgery.
Chiou SM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1156-62. PubMed ID: 20970031
[TBL] [Abstract][Full Text] [Related]
20. Radiological Patterns of Brain Metastases in Breast Cancer Patients: A Subproject of the German Brain Metastases in Breast Cancer (BMBC) Registry.
Laakmann E; Witzel I; Scriba V; Grzyska U; Zu Eulenburg C; Burchardi N; Hesse T; Würschmidt F; Fehm T; Möbus V; von Minckwitz G; Loibl S; Park-Simon TW; Mueller V
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
